We are live on ! Find out more
EP

Elkhorn Partners Portfolio holdings

AUM $157M
1-Year Est. Return 11.91%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+11.91%
3 Year Est. Return
+31.51%
5 Year Est. Return
+35.62%
10 Year Est. Return
+87.18%
AUM
$157M
AUM Growth
+$5.43M
Cap. Flow
+$1.17M
Cap. Flow %
0.75%
Top 10 Hldgs %
95.75%
Holding
52
New
7
Increased
16
Reduced
11
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 46.23%
2 Real Estate 44.05%
3 Communication Services 3.72%
4 Technology 1.87%
5 Materials 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOG
26
ProShares Short Dow30
DOG
$111M
$152K 0.1%
4,700
ACTG icon
27
Acacia Research
ACTG
$450M
$134K 0.09%
32,300
+2,300
+8% +$9.28K
SOFI icon
28
SoFi Technologies
SOFI
$21.1B
$133K 0.09%
16,000
MP icon
29
MP Materials
MP
$7.35B
$114K 0.07%
5,000
+2,600
+108% +$59.6K
RDI icon
30
Reading International Class A
RDI
$32.9M
$113K 0.07%
42,500
BAC icon
31
Bank of America
BAC
$435B
$103K 0.07%
3,600
+200
+6% +$5.71K
KMI icon
32
Kinder Morgan
KMI
$73.1B
$90K 0.06%
5,200
+1,200
+30% +$20.4K
VXX icon
33
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$162M
$88K 0.06%
875
+50
+6% +$7.05K
UAL icon
34
United Airlines
UAL
$38.4B
$85K 0.05%
1,550
-305
-16% -$14.4K
NDAQ icon
35
Nasdaq
NDAQ
$51.5B
$75K 0.05%
+1,500
New +$81.3K
NEPH icon
36
Nephros
NEPH
$39.5M
$70K 0.04%
45,341
-5,000
-10% -$7.38K
CRDF icon
37
Cardiff Oncology
CRDF
$64.3M
$69K 0.04%
47,000
+12,000
+34% +$19.4K
NWLI
38
DELISTED
National Western Life Group, Inc. Class A
NWLI
$66K 0.04%
159
-41
-21% -$13.1K
SCHW
39
Charles Schwab
SCHW
$177B
$58K 0.04%
1,020
+70
+7% +$3.67K
FPH icon
40
Five Point Holdings
FPH
$379M
$49K 0.03%
17,000
OXY icon
41
Occidental Petroleum
OXY
$57B
$41K 0.03%
700
+100
+17% +$6K
BMBL icon
42
Bumble
BMBL
$367M
$39K 0.02%
2,300
+2,000
+667% +$34.5K
MRNA icon
43
Moderna
MRNA
$21.5B
$36K 0.02%
+300
New +$40K
AMZN icon
44
Amazon
AMZN
$2.5T
$18K 0.01%
135
-165
-55% -$18.8K
GS icon
45
Goldman Sachs
GS
$313B
$13K 0.01%
+40
New +$13.2K
CVS icon
46
CVS Health
CVS
$137B
$7K ﹤0.01%
+100
New +$7.12K
LAZ icon
47
Lazard
LAZ
$4.37B
$3K ﹤0.01%
+100
New +$3.09K
CRSP icon
48
CRISPR Therapeutics
CRSP
$4.58B
$2K ﹤0.01%
30
-570
-95% -$32.3K
AMN icon
49
AMN Healthcare
AMN
$1.28B
-500
Closed -$41K
CREX icon
50
Creative Realities
CREX
$41.9M
$0 ﹤0.01%
26

Similar funds

Elkhorn Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Elkhorn Partners held 52 positions worth $157M, up 3.6% from $151M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Elkhorn Partners's Q2 2023 filing shows 7 new, 16 increased, 11 reduced and 3 closed positions. Its largest new stake was Cleveland-Cliffs: 30,000 shares worth $503K. The largest sale was Berkshire Hathaway Class B, an estimated $193K.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 45% a quarter earlier, followed by Real Estate and Communication Services.

  • Elkhorn Partners's largest Q2 2023 buy was Cleveland-Cliffs: 30,000 shares worth $503K.
  • Elkhorn Partners added most to PolyMet Mining Corp. in Q2 2023, an estimated $285K increase.
  • Elkhorn Partners's biggest Q2 2023 reduction was Berkshire Hathaway Class B, cutting an estimated $193K.
  • Elkhorn Partners fully exited AMN Healthcare in Q2 2023, selling an estimated $41K.
  • Elkhorn Partners's ten largest holdings make up 96% of its $157M portfolio in Q2 2023.
  • Elkhorn Partners opened 7 new positions and closed 3 in Q2 2023.
  • Elkhorn Partners's portfolio value rose 3.6% quarter-over-quarter to $157M.

Based on Elkhorn Partners's 13F filing for Q2 2023, filed 14 Aug 2023.